Antitrypanosomal therapy for Chagas disease: A single center experience with adverse drug reactions and strategies for enhancing treatment completion.

Antitrypanosomal therapy for Chagas disease: A single center experience with adverse drug reactions and strategies for enhancing treatment completion.

Anti-trypanosomal therapy is generally recommended for individuals under age 50 with the indeterminate form of Chagas disease to prevent disease progression. However, benznidazole and nifurtimox are associated with adverse drug reactions. We performed a retrospective review of treatment tolerability...

Full description

Saved in:
Bibliographic Details
Main Authors: Katherine Reifler, Alyse Wheelock, Samantha M Hall, Madolyn Dauphinais, Samuel Roytburd, Michael Maiullari, Alejandra Salazar, Ashley Maldonado, Helen Mahoney West, Julia R Köhler, Elizabeth D Barnett, Deepa M Gopal, Davidson H Hamer, Daniel L Bourque
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-07-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0013218
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1371/journal.pntd.0013218

Similar Items